¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"viral infection"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • latent infection
    Àẹ°¨¿°
  • laboratory infection control
    °Ë»ç½Ç°¨¿°°ü¸®
  • local infection
    ±¹¼Ò°¨¿°
  • localized infection
    ±¹¼Ò°¨¿°
  • lymphogenous infection
    ¸²ÇÁ¼º°¨¿°
  • lytic infection
    ¿ë±Õ°¨¿°
  • midpalmar space infection
    Áß°£¼Õ¹Ù´Ú°ø°£°¨¿°
  • milk-borne infection
    ¿ìÀ¯¸Å°³°¨¿°
  • mixed infection
    È¥ÇÕ°¨¿°
  • mock infection
    ¸ðÀǰ¨¿°½ÇÇè
  • multiple infection
    º¹¼ö°¨¿°, ¿©·¯¹ø°¨¿°
  • mycotic infection
    °õÆÎÀ̰¨¿°, Áø±Õ°¨¿°
  • mass infection
    Áý´Ü°¨¿°
  • neonatal infection
    ½Å»ý¾Æ°¨¿°
  • nosocomial infection
    º´¿ø³»°¨¿°
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • intercurrent infection
    º´¹ß°¨¿°
  • introduced infection
    µµÀÔ°¨¿°
  • latent infection
    Àẹ°¨¿°
  • local infection
    ±¹¼Ò°¨¿°
  • localized infection
    ±¹¼Ò°¨¿°
  • lymphogenous infection
    ¸²ÇÁ°¨¿°
  • lytic infection
    ¿ë±Õ¼º°¨¿°
  • mass infection
    Áý´Ü°¨¿°
  • midpalmar space infection
    Áß°£¼Õ¹Ù´Ú°ø°£°¨¿°
  • milk-borne infection
    ¿ìÀ¯¸Å°³°¨¿°
  • mixed infection
    È¥ÇÕ°¨¿°
  • mock infection
    ¸ðÀǰ¨¿°½ÇÇè
  • multiple infection
    ¿©·¯¹ø°¨¿°
  • mycotic infection
    Áø±Õ°¨¿°
  • natural infection
    ÀÚ¿¬°¨¿°
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • hospital infection =nosocomial i.
    ¿ø³»°¨¿°(¡­Êïæø), º´¿ø°¨¿°.
  • hospital infection =nosocomial i.
    ¿ø³»°¨¿°(¡­°¨¿°), º´¿ø°¨¿°.
  • hospital infection control
    ¿ø³»<º´¿ø>°¨¿°°ü¸®
  • huma immunodeficiency virus,follicular dendritic cell infection by
    ¿©Æ÷»ó¼öÁö¼¼Æ÷°¨¿°
  • inapparant infection
    ºÒÇö°¨¿°
  • inapparent infection
    ºÒÇö¼º °¨¿°.
  • indirect contact infection
    °£Á¢Á¢Ã˰¨¿° <Àü¿°>.
  • indirect infection
    °£Á¢°¨¿°.
  • infection
    °¨¿°(Êïæø), Àü¿°(îîæø).
  • infection
    °¨¿°
  • infection allergy
    °¨¿°(Êïæø)¾Ë·¹¸£±â.
  • infection by dirt
    ¿À¹°°¨¿°(çýÚªÊïæø).
  • infection control study
    °¨¿°°ü¸®¿¬±¸
  • infection control surveillance
    °¨¿°°ü¸®°¨½Ã
  • infection cycle
    °¨¿°»ç, °¨¿°È¯
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • adenovirus infection
    ¾Æµ¥³ë¹ÙÀÌ·¯½º°¨¿°.
  • aerial infection = airborne i.
    °ø±â°¨¿°(ÍöѨÊïæø)
  • aerial infection =air borne i.
    °ø±â°¨¿°(ÍöѨÊïæø), ÈíÀÔ°¨¿°(ýåìýÊïæø).
  • aerobic infection
    È£±â±Õ(¼º) °¨¿°(¡­Êïæø).
  • aerosol infection
    ºÐ¹«°¨¿°
  • air borne infection
    °ø±â°¨¿°, ÈíÀÔ°¨¿°.
  • air-borne infection
    °ø±â¸Å°³°¨¿°
  • anaerobic infection
    Çø±â¼º °¨¿°<Àü¿°>(¡­àõÊïæø<îîæø>).
  • anaerobic infection
    Çø±â¼º °¨¿°<Àü¿°>(¡­àõÊïæø<îîæø>).
  • apparent infection
    Çö¼º°¨¿°
  • arthropod infection
    ÀýÁöµ¿¹°¸Å°³°¨¿°.
  • arthropod-borne infection
    ÀýÁöµ¿¹° ¸Å°³°¨¿°
  • ascending infection
    »óÇ༺ °¨¿°.
  • asymptomatic infection
    ¹«Áõ»ó°¨¿°(ÙíñøßÒÊïæø).
  • atrium of infection
    °¨¿°±¸(ÊïæøÏ¢).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
VEA ventricular ectopic activity; ventricular ectopic arrhythmia; viral envelope antigen
VGP viral glycoprotein
VH vaginal hysterectomy; venous hematocrit; ventricular hypertrophy; veterans hospital; viral hepatitis...
VHD valvular heart disease; viral hematodepressive disease
VHF very high frequency; viral hemorrhagic fever; visual half-field
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
vIL-10 Viral interleukin-10
VL Viral load
VPR Viral protein R
AVH acute viral hepatitis
CVH chronic viral hepatitis
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • leptospira infection
    ·¾Å佺ÇÇ¶ó °¨¿°
  • meningococcal infection
    ¼ö¸· ±¸±Õ °¨¿°, ¼ö¸· ±¸±Õ °¨¿°Áõ
  • mock-infection
    ¸ðÀÇ °¨¿° ½ÇÇè
  • multiple infection
    ´Ù¹ß¼º °¨¿°
  • neonatal infection
    ½Å»ý¾Æ °¨¿°
  • nosocomial infection
    ¿ø³» °¨¿°
    º´¿ø¿¡ °ü°èµÈ ¶Ç´Â º´¿ø¿¡¼­ ±âÀÎµÈ °¨¿°.
  • oral infection
    ±¸°­ °¨¿°, ±¸°­ °¨¿°Áõ
  • orthopoxvirus infection
    ¿À¸£Å䯸½º ¹ÙÀÌ·¯½º °¨¿°
  • parasitic infection
    ±â»ýÃæ °¨¿°
  • polymicrobial infection
    º¹¼ö ±Õ °¨¿°
  • postoperative infection
    ¼úÈÄ °¨¿°
  • primary infection
    ¿ø¹ß¼º °¨¿°, ÀÏÂ÷ °¨¿°
  • pseudomonas infection
    ³ì³ó±Õ °¨¿°, ³ì³ó±Õ °¨¿°Áõ
  • pulmonary infection
    Æó °¨¿°
  • pyogenic infection
    È­³ó¼º °¨¿°
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
laboratory infection Accidentally acquired infection in laboratory workers.
(12 Dec 1998)
focal infection An old term which distinguishes local infection's (focal) from generalised infection's (sepsis).
(05 Mar 2000)
focal infection, dental Secondary or systemic infections due to dissemination throughout the body of microorganisms whose primary focus of infection lies in the periodontal tissues.
(12 Dec 1998)
food infection Microbial infection resulting from ingestion of contaminated food.
(09 Oct 1997)
force of infection <epidemiology> The per capita rate at which susceptibles are infected.
(05 Dec 1998)
latent infection An asymptomatic infection capable of manifesting symptoms under particular circumstances or if activated.
(05 Mar 2000)
fungal infection 1. (groin) Tinea cruris is a fungal infection of the perineum, better known as jock itch. This condition is often treated with clotrimazole or miconazole cream. Good general hygiene is vital in the prevention of tinea cruris. Keep the groin area clean and dry and avoid chafing. Launder athletic supporters frequently. Use an antifungal or drying powder after showering.
2. (nail) A fungal infection that involves the fingernails. Nails generally split, flake and grow too thick.
3. (scalp): A fungal scalp infection also known as tinea capitis. A crusting and scaly lesion of the scalp that can also be associated with localised hair loss. Treatment requires oral (systemic) antifungal medications.
(05 Jan 1998)
fungal nail infection The most common fungus infection of the nail is onychomycosis. Onychomycosis makes the nails look white and opaque, thickened, and brittle. Older women (perhaps because oestrogen deficiency may increase the risk of infection) and men and women with diabetes or disease of the small blood vessels (peripheral vacscular disease) are at increased risk. Artificial nails (acrylic or wraps ) increase the risk because when an artificial nail is applied, the nail surface is usually abraded with an emery board damaging it, emery boards can carry infection, and water can collect under the nail creating a moist, warm environment for fungal growth. Alternative names include tinea unguium and ringworm of the nails.
(12 Dec 1998)
lysogenic infection An infective process characterised by the incorporation of the DNA of the infecting phage into the host cell chromosome. Once incorporated, the phage DNA replicates along with the host DNA. The incorporated phage DNA is relatively inactive, thus permitting the host cell to continue fairly normal life processes.
(14 Nov 1997)
lytic infection The normal cycle of infection of a cell by a virus or bacteriophage, in which mature virus or phage particles are produced and the cell is then lysed.
(18 Nov 1997)
acute viral conjunctivitis An epidemic inflammation of the conjunctiva marked by follicles, especially in the lower fornix; may be caused by adenoviruses, herpesvirus, and Newcastle disease virus.
(05 Mar 2000)
antibodies, viral Immunoglobulins produced as a response to viral antigens; includes all classes of immunoglobulins elicited by all viral components.
(12 Dec 1998)
antigens, viral Substances elaborated by viruses that have antigenic activity.
(12 Dec 1998)
antigens, viral, tumour Those proteins recognised by antibodies from serum of animals bearing tumours induced by viruses; these proteins are presumably coded for by the nucleic acids of the same viruses that caused the neoplastic transformation.
(12 Dec 1998)
avian viral arthritis virus A virus of the genus Reovirus, family Reoviridae, causing tenosynovitis and arthritis in chickens.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
ÅëÇÕ°Ë»ö ¿Ï·á